BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11986192)

  • 1. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy.
    Schwarz RE; Zagala-Nevarez K
    Ann Surg Oncol; 2002 May; 9(4):394-400. PubMed ID: 11986192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
    Bilici A; Selcukbiricik F
    Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.
    Wang SB; Qi WX; Chen JY; Xu C; Kirova YM; Cao WG; Cai R; Cao L; Yan M; Cai G
    Radiat Oncol; 2019 Jul; 14(1):128. PubMed ID: 31315683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of the lymph node ratio for local advanced gastric cancer patients with intensity-modulated radiation therapy and concurrent chemotherapy after radical gastrectomy in China.
    Yang Y; Ma Y; Xiang X; Xing P; Wu Y; Zhang L; Tian Y
    Radiat Oncol; 2020 Oct; 15(1):237. PubMed ID: 33054848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer.
    Chang JS; Kim KH; Yoon HI; Hyung WJ; Rha SY; Kim HS; Lee YC; Lim JS; Noh SH; Koom WS
    Br J Surg; 2017 Jun; 104(7):877-884. PubMed ID: 28245053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of survival outcome following radical gastrectomy for gastric cancer.
    Lui SA; Tan WB; Tai BC; Yong WP; Mu YS; Ti TK; Shabbir A; So J
    ANZ J Surg; 2019 Jan; 89(1-2):84-89. PubMed ID: 30690932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pattern and risk factors of recurrence of proximal gastric cancer after curative resection.
    Li F; Zhang R; Liang H; Liu H; Quan J
    J Surg Oncol; 2013 Feb; 107(2):130-5. PubMed ID: 22949400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The patterns and timing of recurrence after curative resection for gastric cancer in China.
    Liu D; Lu M; Li J; Yang Z; Feng Q; Zhou M; Zhang Z; Shen L
    World J Surg Oncol; 2016 Dec; 14(1):305. PubMed ID: 27931221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of death from tumor recurrence after curative gastrectomy for gastric cancer.
    Sakar B; Karagol H; Gumus M; Basaran M; Kaytan E; Argon A; Ustuner Z; Bavbek SE; Bugra D; Aykan FN
    Am J Clin Oncol; 2004 Apr; 27(2):205-9. PubMed ID: 15057162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy.
    Ikoma N; Chen HC; Wang X; Blum M; Estrella JS; Fournier K; Mansfield P; Ajani J; Badgwell BD
    Ann Surg Oncol; 2017 Sep; 24(9):2679-2687. PubMed ID: 28332034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of recurrence in patients with gastric cancer after radical gastrectomy and adjuvant chemotherapy].
    Du C; Guo C; Xu Q; Wang J; Zhou A
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):622-7. PubMed ID: 26714605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical outcomes for gastric cancer patients with intraperitoneal free cancer cell, but no macroscopic peritoneal metastasis.
    Saito H; Kihara K; Kuroda H; Matsunaga T; Tatebe S; Ikeguchi M
    J Surg Oncol; 2011 Oct; 104(5):534-7. PubMed ID: 21618248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
    Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival outcomes and patterns of failure after D2 dissection and adjuvant chemoradiotherapy for locally advanced gastric cancer: a retrospective study.
    Yang W; Hu R; Li GC; Zhou ML; Wang Y; Shen LJ; Liang LP; Zhang Z
    Br J Radiol; 2018 Sep; 91(1089):20170594. PubMed ID: 29927628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
    Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns, timing and risk factors of recurrence of gastric cancer after laparoscopic gastrectomy: reliable results following long-term follow-up.
    Nakagawa M; Kojima K; Inokuchi M; Kato K; Sugita H; Kawano T; Sugihara K
    Eur J Surg Oncol; 2014 Oct; 40(10):1376-82. PubMed ID: 24915857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity.
    Martin RC; Jaques DP; Brennan MF; Karpeh M
    Ann Surg; 2002 Aug; 236(2):159-65. PubMed ID: 12170020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration.
    Chang JS; Kim KH; Keum KC; Noh SH; Lim JS; Kim HS; Rha SY; Lee YC; Hyung WJ; Koom WS
    J Surg Oncol; 2016 Dec; 114(7):859-864. PubMed ID: 27511744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.